These findings demonstrated that blocking the AKT/mTOR signaling pathway abolished the beneficial effect of RRM2, further confirming that RRM2 has a protective effect against DOX-induced cardiomyopathy through the AKT/mTOR signaling pathway. The gene discussed is MTOR; the disease is cardiomyopathy.